Interaction between Insulin Resistance and Factor XIII Val34Leu in Patients with Coronary Artery Disease

Thromb Haemost 1999; 82(03): 1202-1203
DOI: 10.1055/s-0037-1614357

Letters to the Editor

Schattauer GmbH

Authors

Hans P. Kohler

²From the Unit of Molecular Vascular Medicine, Leeds General Infirmary, Leeds, and University Hospital Birmingham NHS Trust, Selly Oak Hospital, Birmingham, UK
Michael W. Mansfield

²From the Unit of Molecular Vascular Medicine, Leeds General Infirmary, Leeds, and University Hospital Birmingham NHS Trust, Selly Oak Hospital, Birmingham, UK
Penny S. Clark

¹Clinical Biochemistry Department, University Hospital Birmingham NHS Trust, Selly Oak Hospital, Birmingham, UK
Peter J. Grant

²From the Unit of Molecular Vascular Medicine, Leeds General Infirmary, Leeds, and University Hospital Birmingham NHS Trust, Selly Oak Hospital, Birmingham, UK

References
1 Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2 Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457-62.
3 Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
4 Wartiovaara U, Perola M, Mikkola H, Tötterman K, Savolainen V, Penttilä A, Grant PJ, Tikkanen MJ, Vartiainen E, Karhunen PJ, Peltonen L, Palotie A. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 1999; 142: 295-300.
5 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.